Get Report Sample Copy @ https://www.factmr.com/connectus/sample?flag=S&rep_id=76
Increasing prevalence of skin ailments such as psoriasis and eczema across the globe and advancement of phototherapy technology is expected to influence the global phototherapy devices market over the next couple of years. As the number of patients with skin conditions continue to soar, urgency of developing advance treatment modules also grows in parallel. The introduction of cost-effective phototherapy devices based on LED technology that are more efficient than the conventional devices is bringing hope to patients. Over the years, phototherapy treatment has continuously evolved due to the arrival of new technological peripherals. Factors as such, have been instrumental in driving the adoption of phototherapy devices. Phototherapy devices are being increasingly used in treating neonatal jaundice, which is common among new born babies with high amount of bilirubinlevels. However, the introduction of alternative mode of treatments and potential risks of side-effects coupled with stringent regulations on product approval remain a major challenge for manufacturers of phototherapy devices. As per the latest report published by Fact.MR, the global phototherapy devices market will expand at 4.7% CAGR over the forecast period (2017-2022)
|Product Type||End User||Light Type|
|Conventional Phototherapy Devices||Hospitals||White Light|
|Fiber Optic Phototherapy Devices||Dermatology Clinics||Red Light|
|Others||Home Care Settings||Blue Light|
Outlook Complete Research Report with TOC @ https://www.factmr.com/report/76/phototherapy-devices-market
North America to Lead the Global Phototherapy Devices Market
In terms of revenue, the phototherapy devices market in North America is expected to remain highly attractive throughout the forecast period. In addition, the region’s market is projected to expand at little under 4% CAGR over 2022. Meanwhile, the markets in Asia-Pacific excluding Japan (APEJ) and Europe are also projected to register a steady growth over the next five years.
On the basis of product type, adoption of the conventional phototherapy devices is significantly high. Global sales of conventional phototherapy devices currently accounts for close to 55% revenue share of the market and this trend is likely to continue in 2017 and beyond.
By end use, the hospitals segment currently accounts for more than 60% market share in terms of revenue. Towards the end of the forecast period, more than US$ 395 Mn worth phototherapy devices are estimated to be installed in hospitals across the globe.
Key players mentioned in Fact.MR’s report include Drägerwerk AG & Co. KGaA, Medela AG, General Electric Company, Natus Medical Incorporated, Hill-Rom, Solarc Systems Inc., The Daavlin Company, Schulze & Böhm GmbH, Medisana AG, Guangzhou Beautylife Electronic Technology co.,Ltd, Herbert Waldmann GmbH & Co. KG, Philips Lighting Holding B.V., National Biological Corp., Nice Neotech Medical Systems Pvt. Ltd., Phoenix Medical Systems Pvt. Ltd., ALFAMEDIC S.R.O., NINGBO DAVID MEDICAL DEVICE CO., LTD., Heal Force Bio-Meditech Holdings Limited, Natus Medical Incorporated and DIXION.
Inquire More or Share Questions if any @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=76
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852